1995
DOI: 10.1016/0306-4522(94)00575-p
|View full text |Cite
|
Sign up to set email alerts
|

[d-Pen2,d-Pen5]Enkephalin, a δ opioid agonist, reduces endogenous aluminum content in the rat central nervous system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1996
1996
2015
2015

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…It has been shown that Al 3+ binds at two metal-binding sites of enkephalin, involving the Tyr1CO and Leu5COO À groups of the neuropeptide in dimethyl sulphoxide solution [130]. Moreover, [D-Pen 2 ,D-Pen 5 ]enkephalin, when intraventricularly injected, transiently reduces the aluminium content of striatum and parietal cortex in chronically exposed rats to AlCl 3 [131]. Rao et al [132] showed that neuropeptide Y complexes with aluminium, altering its biological activity.…”
Section: Neurotransmitter Synthesis and Storagementioning
confidence: 98%
See 1 more Smart Citation
“…It has been shown that Al 3+ binds at two metal-binding sites of enkephalin, involving the Tyr1CO and Leu5COO À groups of the neuropeptide in dimethyl sulphoxide solution [130]. Moreover, [D-Pen 2 ,D-Pen 5 ]enkephalin, when intraventricularly injected, transiently reduces the aluminium content of striatum and parietal cortex in chronically exposed rats to AlCl 3 [131]. Rao et al [132] showed that neuropeptide Y complexes with aluminium, altering its biological activity.…”
Section: Neurotransmitter Synthesis and Storagementioning
confidence: 98%
“…Interestingly, the 5-hydroxytryptamine receptors class 2 couple preferentially to G q /G 11 to increase the hydrolysis of inositol phosphates and elevate cytosolic Ca 2+ concentrations. Chronic systemic in vivo, as well as in vitro, effects of aluminium on opioid receptor binding characteristics were also studied [131]. Neither the specific agonist binding to d nor to l opioid receptors was modified.…”
Section: Neurotransmitter Interaction With Receptorsmentioning
confidence: 99%